Pharma

Rapid test trial to diagnose winter respiratory infections in minutes

NIHR-supported trial tests a rapid, low-cost point-of-care test that can diagnose flu, COVID‑19, and RSV in minutes, potentially speeding up winter diagnosis and care across the NHS.

NICE approves new COPD treatment that cuts flare-ups by 30%

NICE has recommended dupilumab, a first-of-its-kind targeted COPD treatment that reduces flare-ups and improves lung function, offering new hope to thousands of patients.

UCL leads €60m AI-driven drug discovery project launch

UCL joins global €60m AI-driven drug discovery initiative to generate open datasets and accelerate new medicines using AI models across disease areas.

One in six adults in England prescribed corticosteroids in 2023

A national study highlights that more than one in six adults in England received at least one corticosteroid prescription in 2023.

Breakthrough test offers faster, more accurate ibd diagnosis

Researchers in Edinburgh have developed a rapid stool-based test aiming to improve the diagnosis of inflammatory bowel disease and reduce the need for invasive procedures.

Breakthrough Alzheimer’s test using finger-prick blood samples

New finger-prick blood test accurately detects Alzheimer’s biomarkers, enabling at-home collection and broader research.

NICE recommends a new MS treatment option for highly active multiple sclerosis

NICE recommends natalizumab, including a lower-cost biosimilar, as a new treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients.

New nasal vaccine could stop whooping cough spreading, trial finds

A NIHR-backed trial has found that BPZE1, a nasal spray vaccine, can block whooping cough bacteria from colonising the nose and throat.

First volunteer receives Lassa fever vaccine in University of Oxford trial

The first human has been vaccinated with Oxford’s new Lassa fever vaccine in a major first‑in‑human trial.

Shingles vaccine linked to 20% lower risk of dementia in older adults

A new study suggests the shingles vaccine could reduce dementia risk and may even slow progression in those already diagnosed, offering hope for millions.

UK-US pharma deal secures medicine access and investment

The UK-US pharma deal removes tariffs, boosts NHS access to innovative medicines, and drives significant life-sciences investment, safeguarding patients and industry growth.

GSK and Fleming Initiative join forces to fight AMR with advanced AI

GSK is investing £45 m with the Fleming Initiative to launch six “Grand Challenge” research programmes using cutting-edge AI to tackle antimicrobial resistance against pathogens like MRSA, Gram-negative bacteria, and fungi.

New UK vaccine trial targets virus linked to MS

The UK’s Horizon trial will test a vaccine against the Epstein-Barr virus (EBV), linked to multiple sclerosis, aiming to train the immune system and explore a potential new treatment for MS.

NHS hospitals trial 15-minute blood test to detect life-threatening conditions in children

NHS hospitals are piloting a rapid 15-minute blood test to distinguish viral vs bacterial infections in children, enabling faster diagnosis and treatment of serious illnesses like sepsis and meningitis.

Lab-grown human embryo model creates blood stem cells in major Cambridge breakthrough

Cambridge scientists grow ‘hematoids’, embryo-like structures from stem cells that generate blood stem cells after two weeks.

University of Surrey joins global project to create immune digital twins

Researchers at the University of Surrey are creating immune digital twins, virtual models of individual immune systems, to advance personalised medicine and deliver tailored treatments.

UEA develops blood test for ME/CFS with 96% accuracy

A groundbreaking blood test from UEA can diagnose ME/CFS with 96% accuracy, offering hope for patients and new insights into chronic fatigue syndrome.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders